Delivery Order SPE2DB20D3103-SPE2DB25FP7G4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $22,892.70 to AmerisourceBergen Drug Corp for the supply of Tadliq 20 mg/5 ml suspension (150 ml) on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen's Corporate Office is headquartered. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,060.43 to AmerisourceBergen Drug Corp for the supply of TADLIQ 20 mg/5 ml suspension in 150ml quantities. This firm fixed-price, non-set-aside delivery order was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,219.11 to Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of TADLIQ 20 MG/5 ML SUSPENSION 150ML, a pharmaceutical product, with a completion date of February 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,219.11 Firm Fixed Price Delivery Order is for the supply of TADLIQ 20 MG/5 ML SUSPENSION 150ML, with a period of performance through October 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
- The Defense Logistics Agency (DLA) awarded a $3,657.33 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp for the supply of "4565602636 ! TADLIQ 20 MG/5 ML SUSPENSION 150ML". This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,586.87 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a $13,963.18 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Talvey 40 mg/ml vials. This firm fixed-price, competitively awarded contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order carries no set-aside designation and represents a relatively small-value transaction within the contractor's broader federal...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $4,216.30 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award represents a pharmaceutical delivery to be...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,724.96 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA and carries no set-aside designation. The order will be fulfilled from the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $4,027.02 delivery order to AmerisourceBergen Drug Corp for Quilpta 60 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP7G4Delivery Order
The Defense Logistics Agency awarded a $5,966.66 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Tadliq 20 mg/5 ml Suspension in 150 ml quantities, with an ultimate completion date of August 5, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order for pharmaceutical products to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs worldwide. AmerisourceBergen's continued selection for such delivery orders reflects its established capability to meet federal procurement requirements through open competition and its critical role as a major pharmaceutical distributor within the Defense Logistics Agency's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 8/4/25 |